The main purpose of this legislative text is to update the Federal Food, Drug, and Cosmetic Act to allow artificial intelligence (AI) and machine learning technologies to be recognized as eligible practitioners who can prescribe drugs. This change aims to integrate advanced technology into healthcare, ensuring that these technologies can play a role in medication management when they meet specific state and federal requirements. Key provisions of this legislation include the definition of AI and machine learning technologies as "practitioners" who can prescribe drugs.